Nancy Briefs

New View Surgical is a Minimally Invasive Surgery (MIS) company focused on improving the outcomes of laparoscopic surgical procedures through the commercialization of clinically and economically superior visualization technologies. The Company is developing VisionPort™, a family of products that is the first truly major advancement in MIS visualization since the development of the video computer chip three decades ago that allowed surgeons to view surgery on a TV monitor. The innovative VisionPort will simplify minimally invasive procedures, give surgeons greater control, improve safety and enhance technical proficiency. Additionally, it will significantly reduce the costs associated with visualization systems that play a critical role in MIS.

Health Helm, Inc. is a closed-loop communication platform between patients and their physicians that enables patients to take charge of their personal health. Trusted Patient Coach (TPC) is Health Helm's premium, clinically tested software. TPC securely connects patients with their physicians via mobile and desktop communication. Following discharge from the hospital, TPC enables medication adherence tracking and provides reminders, and assists patients in monitoring their symptoms and vital signs. In using this care plan enhancement and support, studies show that patients are far more likely to achieve better outcomes. Health Helm strives to ensure that patients feel in control of their health!

Plataforma de Conteúdo e Capacitação sobre Investimento em Startups

StageNext invests in companies led by seasoned women entrepreneurs. Our vision is to establish StageNext as the strategic co-investor of choice for the entrepreneurs we back, the lead investors we follow, and the networks who refer their companies to us.

Founded in 2019, AltrixBio is based on research by Jeff Karp, PhD, and Ali Tavakkoli, MD, of Mass General Brigham and Harvard Medical School. Inspired by the rapid resolution of type 2 diabetes following bariatric surgery, they modified sucralfate—a therapy with over 40 years of clinical use—to replicate these metabolic benefits, creating AJN003, a proprietary, bio-engineered, once-daily oral therapy. AJN003 forms a temporary barrier in the stomach, duodenum, and jejunum, altering nutrient sensing to trigger a metabolic reset. Preclinical data show it improves insulin resistance and key metabolic hormones (GLP-1, GIP, ghrelin, leptin), driving improved glycemic control and weight loss. As a small molecule with no systemic exposure, AJN003 offers a novel, patent-protected approach to treating type 2 diabetes, obesity, and other metabolic diseases. The AltrixBio team comprises scientists, clinicians, and business leaders with deep scientific, operational, and commercial expertise.

New View Surgical is a Minimally Invasive Surgery (MIS) company focused on improving the outcomes of laparoscopic surgical procedures through the commercialization of clinically and economically superior visualization technologies. The Company is developing VisionPort™, a family of products that is the first truly major advancement in MIS visualization since the development of the video computer chip three decades ago that allowed surgeons to view surgery on a TV monitor. The innovative VisionPort will simplify minimally invasive procedures, give surgeons greater control, improve safety and enhance technical proficiency. Additionally, it will significantly reduce the costs associated with visualization systems that play a critical role in MIS.